Mirati: 2Q Earnings Snapshot
SAN DIEGO (AP) _ Mirati Therapeutics Inc. (MRTX) on Monday reported a loss of $45.7 million in its second quarter.
The San Diego-based company said it had a loss of $1.26 per share.
The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.21 per share.
The biopharmaceutical company posted revenue of $577,000 in the period.
Mirati shares have more than doubled since the beginning of the year. In the final minutes of trading on Monday, shares hit $93.65, a rise of 63% in the last 12 months.